Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Filovirus Fusion Proteins and Their Uses, 5388 [2014-01936]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES 5388 Federal Register / Vol. 79, No. 21 / Friday, January 31, 2014 / Notices missions, the Army completed numerous interior modifications, including creating doorways and windows and altering the interior lateral cross-bracing. The lack of rehabilitation, interior modifications, the age of the structures, a fire in Hangar 2, and the harsh Alaskan environment all have contributed to the compromised structural integrity of both buildings. The United States Army Garrison Fort Wainwright, Alaska (USAG FWA) has condemned the buildings, and they are no longer used because they present a safety hazard. The Final EIS has been prepared in accordance with the National Environmental Policy Act of 1969 (NEPA), as amended (42 United States Code § 4321 et seq.); NEPAimplementing regulations issued by the President’s Council on Environmental Quality (40 Code of Federal Regulations [CFR] §§ 1500–1508); and the Army’s NEPA-implementing regulation (32 CFR § 651, Environmental Analysis of Army Actions). The purpose of the Final EIS is to inform the decision makers, agencies, interested parties, Alaska Native tribes, and the public of possible environmental consequences associated with the reasonable disposition alternatives for Hangars 2 and 3. The USAG FWA entered into consultation concerning the proposed disposition of Hangars 2 and 3 as required by Section 106 of the National Historic Preservation Act and its implementing regulations (36 CFR § 800). The USAG FWA concludes that the disposition would result in historic properties being adversely affected. The disposition of the hangars would adversely affect the hangars as contributing resources to the Ladd Field NHL and the Cold War Historic District and, in so doing, would adversely affect both districts. The Army entered into a Memorandum of Agreement (MOA) with the Alaska State Historic Preservation Office and the Advisory Council on Historic Preservation pursuant to 36 CFR § 800.6(2)(c) to mitigate adverse effects. Mitigation measures provided in the MOA require public outreach in the pursuit of more visibility and appreciation for the Ladd Field NHL, reevaluation of the Ladd Field NHL, and stewardship of the Ladd Field NHL. Mitigation under the No Action Alternative would be the same as under Alternative 1, except the time frame for completing the stipulations would be based on the date of execution of the MOA rather than on the demolition of the hangars. VerDate Mar<15>2010 22:14 Jan 30, 2014 Jkt 232001 Public and agency comments received on the Draft EIS did not result in modification of the alternatives or the environmental analysis; therefore, the full text of the EIS has not been reprinted. Instead, an erratum was prepared to supplement the Draft EIS, and these two documents together constitute the Final EIS for the Disposition of Hangars 2 and 3 at Fort Wainwright, Alaska. Public and agency comments received on the Draft EIS and government responses can be found in Appendix E of the Final EIS. Comments received resulted in the inclusion of two additional mitigation measures in the final National Historic Preservation Act (NHPA) Section 106 Memorandum of Agreement. These additional mitigation measures are also appropriately reflected in the Final EIS, Section 3.0 Errata Sheet Revisions to be Made to the Draft Environmental Impact Statement. An electronic version of the Final EIS can be viewed or downloaded from the following Web site: https:// www.wainwright.army.mil/env/NEPA/ Current.html Copies of the Final EIS will also be available for review at the Noel Wien Public Library in Fairbanks, Alaska. FOR FURTHER INFORMATION CONTACT: Brenda S. Bowen, Army Federal Register Liaison Officer. ACTION: [FR Doc. 2014–01851 Filed 1–30–14; 8:45 am] SUMMARY: BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Health Outcome Prediction and Management System and Method AGENCY: ACTION: Department of the Army, DoD. Notice. Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/910,254, entitled ‘‘Health Outcome Prediction and Management System and Method,’’ filed on June 5, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. The invention relates to systems, methods and apparatus for providing statistical estimates useful for decision support, including computer networks and software configured to provide such support. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01932 Filed 1–30–14; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Filovirus Fusion Proteins and Their Uses AGENCY: Department of the Army, DoD. Notice. Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/882,041, entitled ‘‘Filovirus Fusion Proteins and Their Uses,’’ filed on April 26, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to the use of the Filovirus glycoprotein fusion proteins for the prevention and diagnosis of Filovirus infection. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01936 Filed 1–30–14; 8:45 am] BILLING CODE 3710–08–P E:\FR\FM\31JAN1.SGM 31JAN1

Agencies

[Federal Register Volume 79, Number 21 (Friday, January 31, 2014)]
[Notices]
[Page 5388]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01936]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Filovirus 
Fusion Proteins and Their Uses

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 13/882,041, 
entitled ``Filovirus Fusion Proteins and Their Uses,'' filed on April 
26, 2013. The United States Government, as represented by the Secretary 
of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the use of the 
Filovirus glycoprotein fusion proteins for the prevention and diagnosis 
of Filovirus infection.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01936 Filed 1-30-14; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.